scholarly journals COVID 19 pandemic: Lesson learned by South Korea and its application with India’s perspective

2020 ◽  
Vol 32 (3) ◽  
pp. 608-609
Author(s):  
Smita Sinha ◽  
Rishita Chandra

A novel coronavirus named as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in December 2019, in Wuhan city of Hubei province of China, which got transmitted throughout the nation and even world. It was declared as a Public Health Emergency by WHO on January 30th 2020, due to the increase in the number of cases reported from various regions of WHO with the evidence of human to human transmission. (1) Spread of COVID-19 across the globe: China reported first COVID-19 death on January 11th 2020.  After a few weeks, 830 cases were diagnosed in China along with 26 reported deaths. By January 20, Wuhan was placed under lockdown and China alerted other nations about its spread in various provinces. (2) This contagious disease had spread to 24 nations outside China-Hong Kong-Macau, by 2nd February.  About 172 countries and regions were engulfed by this virus by March 25, 2020. (3) Globally over 3,308,643 cases have been confirmed, over 234,123 deaths have been reported, and around 1,042,981 have recovered as on 30th April 2020. (4) Controlling the Pandemic COVID 19: success story of the Republic of Korea: Initially, one country which successfully stood out from the rest of the world was South Korea. The country confirmed its first few cases in late January and then reported a surge in the cases a few weeks later. The country was exploded with cases in dozens to hundreds to thousands during late February and early March and launched drive-through testing centers and massive contact tracing. Almost 909 new cases were identified in a single day of February 29th 2020 and was reported at peak. This data brought the country with 50 million population on the verge of a deluge. But the number of new cases was halved within a time period of just a week. The number of cases reduced to half within four days, and it halved, again the following day. (5)    

2020 ◽  
Vol 32 (2 (Supp)) ◽  
pp. 306-308 ◽  
Author(s):  
Giriyanna Gowda ◽  
Ramesh Holla ◽  
Balaji Ramraj ◽  
Kishore Shettihalli Gudegowda

Covid 19 caused by SARS-coV-2 is a novel corona virus. This began in Wuhan city, China at the end of December 2019 and had spread to the rest of the world. World Health Organization (WHO) declared Covid 19 as Public Health Emergency of International Concern (PHEIC) on 30th Jan 2020 and later declared as pandemic on 11th march 2020. 1 The disease is mainly spread from human to human through small droplets from nose or mouth when a person with Covid 19 coughs or exhales and through the surface contact. Community surveillance plays significant role in prevention of spread of disease. It includes isolation of the positive case, quarantine of the high risk and low risk contacts and community disinfection.1, 2             The period of communicability is estimated with the current data to be from 2 days before the onset of symptoms and up to 2 weeks after onset. Hence the initial few asymptomatic days turns out to be crucial period in containing the spread of infection. By the time a Covid 19 patient is diagnosed and isolated, there are quite a number of primary and secondary contacts. Government of India focus has been on Community Surveillance activities which mainly comprises of Contact Tracing and Quarantine.3, 4 This article focuses on the various measures taken to trace the contacts, quarantine measures and on the challenges faced.


2020 ◽  
Vol 8 (5) ◽  
pp. 204-206
Author(s):  
Sharin Baldwin ◽  
Patricia Kelly

Novel coronavirus was first identified in Wuhan City, China and was reported to the World Health Organization (WHO) in China on 31 December, 2019. On 30 January, WHO declared the outbreak of COVID-19 a ‘public health emergency of international concern’. Since then, the virus has spread rapidly across the world, with the WHO declaring it a pandemic on 11 March 2020. This article describes a case study where two health visitors were able to adapt and use their wide-ranging skills to support frontline health professionals in acute settings to meet the demands placed on them during these unprecedented times.


Sensors ◽  
2020 ◽  
Vol 20 (22) ◽  
pp. 6591
Author(s):  
Badriyah Alhalaili ◽  
Ileana Nicoleta Popescu ◽  
Olfa Kamoun ◽  
Feras Alzubi ◽  
Sami Alawadhia ◽  
...  

The coronavirus disease 2019 (COVID-19) pandemic is considered a public health emergency of international concern. The 2019 novel coronavirus (2019-nCoV) or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that caused this pandemic has spread rapidly to over 200 countries, and has drastically affected public health and the economies of states at unprecedented levels. In this context, efforts around the world are focusing on solving this problem in several directions of research, by: (i) exploring the origin and evolution of the phylogeny of the SARS-CoV-2 viral genome; (ii) developing nanobiosensors that could be highly effective in detecting the new coronavirus; (iii) finding effective treatments for COVID-19; and (iv) working on vaccine development. In this paper, an overview of the progress made in the development of nanobiosensors for the detection of human coronaviruses (SARS-CoV, SARS-CoV-2, and Middle East respiratory syndrome coronavirus (MERS-CoV) is presented, along with specific techniques for modifying the surface of nanobiosensors. The newest detection methods of the influenza virus responsible for acute respiratory syndrome were compared with conventional methods, highlighting the newest trends in diagnostics, applications, and challenges of SARS-CoV-2 (COVID-19 causative virus) nanobiosensors.


2021 ◽  
Vol 75 ◽  
pp. 91-100
Author(s):  
Arezoo Mirzaei ◽  
Sharareh Moghim

The recent continuously emerging rampancy of novel coronavirus (SARS-CoV-2) that started in Wuhan in late December 2019 has become an international public health emergency and is still spreading rapidly in the world. Up to October 11, 2020, 37.109.6851 confirmed cases of COVID-19 have been announced with 2.8 percent death, which means 1.070.355 confirmed death cases. At the moment, a specific vaccine or drug for the new coronavirus is not available; thus, the development of a drug with far-reaching HCoV inhibitory activity is an urgent medical need. It is, however, vital to first comprehend the nature of this family and other coronaviruses that have caused the outbreak. Here, we relate the epidemiological and virological characteristics of the COVID-19, SARS, and MERS rampancy.


2020 ◽  
Vol 67 (1) ◽  
pp. 6-6
Author(s):  
Ken Thai

Pharmacists and our fellow healthcare colleagues typically expect a break from our “high season” of cough, cold, and flu patients that have filled our pharmacies, clinics, and hospitals by this time of the year. Everyone is prepping for the end of the winter and the dawning of spring. This year was unlike many as we have heard loud cries across the globe regarding the outbreak of the novel “new” coronavirus. The virus was first detected from the Wuhan City of China. It has since infected tens of thousands of people in China and across the world. In fact, the World Health Organization has declared the outbreak a “public health emergency of international concern.” Health and Human Services Secretary Alex Azar declared a public health emergency for the United States to aid the nation's healthcare community in responding. A proclamation was signed on January 31, 2020, by the United States to suspend entry of anyone who poses a risk of transmitting the coronavirus.


Author(s):  
Yongchang Xu ◽  
Leyi Wang ◽  
Xu Jia ◽  
Youjun Feng

A novel coronavirus (2019-nCoV) that is initially found to trigger human severe respiratory illness in Wuhan City of China, 2019, has been recognized as a public health emergency of international concern. In the past two months, this deadly agent has caused 77,785 cases with 2,666 deaths via rapid person-to-person transmission and reached at least 25 countries. However, its evolutionary origin is poorly understood. Here we show integrative evidence that 2019-nCoV is a possible progenitor for SARS-CoV with bat origin. Our finding underscores the importance of tracing origin in the efficient monitoring, and effectively preventing the interspecies transmission of such emerging/re-emerging coronaviruses.


Author(s):  
Nikita Jatai ◽  
Tanu Sharma ◽  
Karan Veer

All over the world, there is a new target of public health emergency looming the world along with an appearance and distribution of the novel coronavirus disease (2019-nCoV) also known as Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2). This Virus initially generated in bats and then after transferred to a human being over unknown animal playing the role of mediator in Wuhan, China in December 2019. This virus is passed by breathing or in contact with an infected person’s droplets. The Incubation period is between 2 to 14 days for COVID-19, that is the time between exposure of the virus (person becoming infected) and symptom on that person, is on an average of 5-6 days, however it can goes up to 14 days. Throughout this period, which can be also known as “pre-symptomatic” period, some of the infected patients or persons can be contagious. That is why, transferal from a pre-symptomatic case can happen before the symptoms onset. Where there is few number of case studies and reports, pre-symptomatic transferal has been documented via contact with someone who is diagnosed with virus and increase investigation of that particular clusters of total confirmed cases. The main problem is that the symptoms are just like the regular flu that are cough, fever, sore throat, fatigue and breathlessness. This virus is moderate or mild in most of the people, but in elder ones, it may proceed to pneumonia, multi-organ dysfunction and Acute Respiratory Distress Syndrome (ARDS). Coronavirus has significant consequences on the Health system, mainly on cardiovascular diseases and on the environment.


Author(s):  
Anuj K. Pandey ◽  
Sidharth S. Mishra ◽  
Yogesh Wadgave ◽  
Nidhi Mudgil ◽  
Sonal Gawande ◽  
...  

The outbreak of novel coronavirus disease (COVID-19) was initially noticed in a seafood market in Wuhan city in Hubei Province of China in mid-December 2019 which has now spread to 223 countries/territories/areas worldwide. World Health Organization (WHO) under International Health Regulations (IHR) has declared this outbreak as a public health emergency of international concern (PHEIC) on 30th January 2020 subsequently declared a pandemic on 11th March 2020.


2020 ◽  
Vol 54 (4s) ◽  
pp. 3-4
Author(s):  
George Amofah

The year 2020 has looked like a fairy tale as the COVID-19 pandemic swept across the world with devastating socio-economic and health consequences. The impact of the pandemic has depended, largely, on preparedness and response of countries, and their ability to adjust to the fast-evolving pandemic. The World Health Organization (WHO) declared the novel coronavirus outbreak a public health emergency of international concern (PHEIC) on 30th January 2020, and Ghana reported its first two confirmed cases on 12th March 2020.


: The novel coronavirus (COVID-19) has effected the 213 countries around the world.It has declared a Public Health Emergency of International Concern on 30 January 2020 by WHO and created tremendous chaos around the world, affecting people’s lives and causing a large number of deaths. On the date of 21st April 2020 total covid confirmed cases are 5,090,977,recovered cases are 2,025,878 and death cases are 329,757. To study the relation between the confirmed ,recovered and death cases in India this study has been undertaken . For the same Ratio analysis technique is used. Here will trying to find that the number of recovered cases will have effect the number of death cases.


Sign in / Sign up

Export Citation Format

Share Document